1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Cognitive Dysfunction in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, X | 1 |
| He, R | 1 |
| Han, W | 1 |
| Li, T | 1 |
| Xie, L | 1 |
| Cheng, L | 1 |
| Chen, H | 1 |
| Xie, M | 1 |
| Jiang, L | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cognitive Dysfunction
| Article | Year |
|---|---|
Protective effects of the ROCK inhibitor fasudil against cognitive dysfunction following status epilepticus in male rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Axons; Brain; CA1 Region, Hippocampal; Cogni | 2019 |